Nifedipine ER
Nifedipine ER is a pharmaceutical drug with 7 clinical trials. Currently 3 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
5
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
4 of 4 finished
0.0%
0 ended early
3
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Oral Combined Hydrochlorothiazide/Lisinopril Versus Oral Nifedipine for Postpartum Hypertension
Intensive Postpartum Antihypertensive Treatment
Reducing the Risk of Chronic Hypertension and Improving Vascular Function Following Preeclampsia
Amlodipine Versus Nifedipine ER for the Management of Postpartum Hypertension
Effect of a Proposed Cav1.3 Inhibitor in Primary Aldosteronism
Clinical Trials (7)
Oral Combined Hydrochlorothiazide/Lisinopril Versus Oral Nifedipine for Postpartum Hypertension
Intensive Postpartum Antihypertensive Treatment
Reducing the Risk of Chronic Hypertension and Improving Vascular Function Following Preeclampsia
Amlodipine Versus Nifedipine ER for the Management of Postpartum Hypertension
Effect of a Proposed Cav1.3 Inhibitor in Primary Aldosteronism
Labetalol or Nifedipine for Control of Postpartum Hypertension: A Randomized Controlled Trial
Comparing Nifedipine and Enalapril in Medical Resources Used in the Postpartum Period
All 7 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 7